Lab Automation Market to exceed US$ 8.71 Billion by 2031

Published on 16-Sep-2025
     Request For Sample

Report : Lab Automation Market Report: Size, Share and Outlook by 2031

According to our latest study on "Lab Automation Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis - by Type, Equipment, Application, and End User," the lab automation market size was valued at US$ 5.76 billion in 2024 and is expected to reach US$ 8.71 billion by 2031; it is estimated to record a CAGR of 6.3% from 2025 to 2031.

The lab automation market is segmented into five major regions-North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. North America dominated the market in 2024, followed by Europe and Asia Pacific, respectively. The Europe lab automation market is segmented into Germany, France, UK, Italy, Spain, and the Rest of Europe. In terms of revenue, Germany dominated the lab automation market share in 2024. German laboratories are adopting high-throughput automation systems to streamline clinical diagnostics, genomic sequencing, and drug development workflows. With a growing emphasis on precision medicine and digital health, automation is becoming central to hospital-based and independent laboratory operations. Companies such as Siemens Healthineers-headquartered in Erlangen-are global diagnostics and laboratory automation leaders. Siemens' Atellica Solution platform is widely used across Germany to optimize lab throughput, standardization, and data integration. International firms such as QIAGEN, headquartered in Hilden, are strengthening their foothold with automated sample preparation systems such as QIAsymphony and the forthcoming QIAsymphony Connect. Germany's strong regulatory standards and high labor costs make automation an economically viable and quality-assuring investment.

Amid accelerating advancements in precision medicine and biotechnology, laboratories across the Asia-Pacific region are turning to automation to enhance efficiency, scalability, and data accuracy. In response to these evolving needs, MGI Tech Co., Ltd., a global leader in life science and healthcare innovation, has unveiled a strategic expansion of its automation portfolio to transform laboratory workflows and support various applications from research to clinical diagnostics. On January 30, 2024, MGI Tech Co., Ltd., an innovator in life science and healthcare research technologies, announced a strategic expansion of its automation product portfolio. The expanded offering spans the full automation spectrum-from sample pretreatment and preparation to integrated testing-drawing on MGI's deep expertise in genetic sequencing and multi-omics. These advanced solutions enhance laboratory throughput, consistency, and scalability, supporting various applications from clinical diagnostics to scientific research. The move reinforces MGI's commitment to enabling more efficient, data-driven workflows across complex life science environments.

As regional laboratories and research institutions modernize processes and improve accuracy while handling larger volumes of data, MGI's automation solutions are well-positioned to meet these evolving demands. By aligning its product development with the unique needs of the Asia Pacific market, MGI is broadening its commercial footprint and contributing to the advancement of high-throughput, technology-enabled healthcare and life sciences across the region.

Key Findings of Lab Automation Market Study:

The lab automation market is segmented into type, equipment, application, and end user. By application, is segmented into clinical diagnostics, drug discovery, proteomics solutions, genomics solutions, and others. The clinical diagnostics segment held the largest share of the lab automation market in 2024. Clinical diagnostics automation enhances diagnostic testing speed, accuracy, and standardization, particularly in high-volume settings such as hospital laboratories, pathology labs, and national diagnostic centers. Automated systems handle routine and specialized tasks, including sample sorting, barcode scanning, centrifugation, reagent dispensing, analyte detection, and result reporting. This handling improves workflow efficiency and reduces human error and turnaround time, critical for timely clinical decision-making. Automation in diagnostics is vital in managing increased testing demands, such as during pandemic surges or chronic disease screening programs. Additionally, integrated automation systems help laboratories meet strict regulatory standards (such as CLIA or ISO 15189) by ensuring full traceability, auditability, and quality control. As the global healthcare system adopts personalized and preventive medicine, the need for highly automated and data-connected diagnostic laboratories grows significantly.

Thermo Fisher Scientific Inc.; Siemens AG; Danaher Corp; Honeywell International Inc; Agilent Technologies Inc; Revvity Inc; Analytik Jena GmbH+Co. KG; Abbott Laboratories; Eppendorf SE; and bioMerieux SA are among the key players profiled in the lab automation market report. Several other major players were studied and analyzed during the lab automation market analysis to get a holistic view of the market and its ecosystem. The lab automation market also provides detailed market insights, which help the key players strategize their growth. The report includes growth prospects owing to the current lab automation market trends and their foreseeable impact during the forecast period.

Contact Us
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com

Get Free Sample PDF

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?


Recent Posts